Does ROMOSOZUMAB-AQQG Cause Peripheral swelling? 106 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 106 reports of Peripheral swelling have been filed in association with ROMOSOZUMAB-AQQG. This represents 0.9% of all adverse event reports for ROMOSOZUMAB-AQQG.
106
Reports of Peripheral swelling with ROMOSOZUMAB-AQQG
0.9%
of all ROMOSOZUMAB-AQQG reports
0
Deaths
10
Hospitalizations
How Dangerous Is Peripheral swelling From ROMOSOZUMAB-AQQG?
Of the 106 reports, 10 (9.4%) required hospitalization, and 1 (0.9%) were considered life-threatening.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROMOSOZUMAB-AQQG. However, 106 reports have been filed with the FAERS database.
What Other Side Effects Does ROMOSOZUMAB-AQQG Cause?
Fall (646)
Fracture (612)
Arthralgia (517)
Injection site pain (490)
Bone density abnormal (454)
Off label use (419)
Hospitalisation (381)
Headache (360)
Product storage error (348)
Death (263)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which ROMOSOZUMAB-AQQG Alternatives Have Lower Peripheral swelling Risk?
ROMOSOZUMAB-AQQG vs ROPEGINTERFERON ALFA-2B-NJFT
ROMOSOZUMAB-AQQG vs ROPINIROLE
ROMOSOZUMAB-AQQG vs ROPIVACAINE
ROMOSOZUMAB-AQQG vs ROSIGLITAZONE
ROMOSOZUMAB-AQQG vs ROSUVASTATIN